Canada · Delayed Price · Currency is CAD Nirvana Life Sciences Statistics
Total Valuation
CSE:NIRV.X has a market cap or net worth of CAD 229,233. The enterprise value is 364,763.
| Market Cap | 229,233 |
| Enterprise Value | 364,763 |
Important Dates
The next estimated earnings date is Tuesday, September 8, 2026.
| Earnings Date | Sep 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:NIRV.X has 22.92 million shares outstanding. The number of shares has decreased by -38.43% in one year.
| Current Share Class | 22.92M |
| Shares Outstanding | 22.92M |
| Shares Change (YoY) | -38.43% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 11.91% |
| Owned by Institutions (%) | n/a |
| Float | 18.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -166.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,018.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 53.30% |
| Weighted Average Cost of Capital (WACC) | 1.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.48% in the last 52 weeks. The beta is -0.57, so CSE:NIRV.X's price volatility has been lower than the market average.
| Beta (5Y) | -0.57 |
| 52-Week Price Change | -90.48% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 41.64 |
| Average Volume (20 Days) | 5,783 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -332,059 |
| Pretax Income | -358,720 |
| Net Income | -358,633 |
| EBITDA | n/a |
| EBIT | -332,059 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 1,347 in cash and 142,173 in debt, with a net cash position of -140,826 or -0.01 per share.
| Cash & Cash Equivalents | 1,347 |
| Total Debt | 142,173 |
| Net Cash | -140,826 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -709,221 |
| Book Value Per Share | -0.03 |
| Working Capital | -622,947 |
Cash Flow
| Operating Cash Flow | -880,322 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 56,046 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:NIRV.X does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 38.43% |
| Shareholder Yield | 38.43% |
| Earnings Yield | -156.45% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Mar 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |